Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease–Free Survival, and Mortality Risk
Open Access
- 5 February 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (2) , e200129
Abstract
Lipoprotein(a) (Lp[a]) consists of a low-density lipoprotein attached to apolipoprotein(a) by a disulfide bond. Plasma levels of Lp(a) are associated with a higher risk of a broad range of atherosclerotic cardiovascular disease (CVD).1-5 The evidence linking Lp(a) levels and Lp(a)-raising genetic variants with all-cause mortality is not as consistent. A 1998 study of healthy centenarian individuals initiated a debate about the potential association between Lp(a) and longevity following the report that up to one-quarter of that population had high Lp(a) levels in the absence of any atherosclerotic CVD.6 Another study of patients with documented coronary heart disease found no evidence of an association between high Lp(a) levels and all-cause mortality.7 A recently published study by Langsted et al8 revealed an association between high Lp(a) levels and cardiovascular and all-cause mortality in the general Danish population. This association could be owing to the fact that individuals with high Lp(a) levels are typically characterized by a smaller apolipoprotein(a) isoform size.Keywords
This publication has 28 references indexed in Scilit:
- Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participantsAging, 2016
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionInternational Journal of Epidemiology, 2015
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old AgePLOS Medicine, 2015
- Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve StenosisCirculation: Cardiovascular Genetics, 2014
- Genetic Associations with Valvular Calcification and Aortic StenosisNew England Journal of Medicine, 2013
- Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Assessing the Impact of Classical Risk Factors on Myocardial Infarction by Rate Advancement PeriodsAmerican Journal of Epidemiology, 2000
- EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer.1999
- Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factorsThe FASEB Journal, 1998